149 related articles for article (PubMed ID: 9225642)
1. Oral contraception and cerebral thromboembolism.
Lidegaard O
Acta Obstet Gynecol Scand Suppl; 1997; 164():66-8. PubMed ID: 9225642
[TBL] [Abstract][Full Text] [Related]
2. [Oral contraceptives and cerebral thromboembolism. A Danish case-control study].
Lidegaard O
Ugeskr Laeger; 1993 Nov; 155(44):3538-45. PubMed ID: 8236574
[TBL] [Abstract][Full Text] [Related]
3. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
Lidegaard O
BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
[TBL] [Abstract][Full Text] [Related]
4. The case for a lower dose pill. Assessing the impact of estrogen dose.
Brown S; Cropfield O
ORGYN; 1995; (2):36-9. PubMed ID: 12319251
[TBL] [Abstract][Full Text] [Related]
5. [Use of oral contraceptives in Denmark 1980-1990 and smoking habits among fertile women in 1990].
Lidegaard O
Ugeskr Laeger; 1993 Nov; 155(44):3550-8. PubMed ID: 8236576
[TBL] [Abstract][Full Text] [Related]
6. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
Hannaford PC; Kay CR
Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
[TBL] [Abstract][Full Text] [Related]
7. [Decline in cerebral thromboembolism among younger women after introduction of low-dose oral contraceptives. A study of the incidence for the period 1980-1995].
Lidegaard O
Ugeskr Laeger; 1996 Oct; 158(42):5933-9. PubMed ID: 8928281
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptive risks: a realistic appraisal.
Bressler R; Durand JL
Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
[TBL] [Abstract][Full Text] [Related]
9. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
10. [Vascular disease and hormonal treatment--epidemiology].
Vessey MP
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
[TBL] [Abstract][Full Text] [Related]
11. Relationship of migraine headache and stroke to oral contraceptive use.
Benson MD; Rebar RW
J Reprod Med; 1986 Dec; 31(12):1082-8. PubMed ID: 3540297
[TBL] [Abstract][Full Text] [Related]
12. [Oral contraception and cerebral embolisms].
Riedel M; Lichtlen PR
Dtsch Med Wochenschr; 1993 Oct; 118(41):1506-7. PubMed ID: 8404516
[TBL] [Abstract][Full Text] [Related]
13. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
[TBL] [Abstract][Full Text] [Related]
14. [Cerebral thromboembolism, oral contraceptives and pregnancy].
Lidegaard O; Andersen MV; Søe M
Ugeskr Laeger; 1987 Aug; 149(32):2135-7. PubMed ID: 3450019
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
Rekers H; Norpoth T; Michaels MA
Eur J Contracept Reprod Health Care; 1996; 1(1):21-30. PubMed ID: 9678134
[TBL] [Abstract][Full Text] [Related]
16. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
[TBL] [Abstract][Full Text] [Related]
17. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
Cole JA; Norman H; Doherty M; Walker AM
Obstet Gynecol; 2007 Feb; 109(2 Pt 1):339-46. PubMed ID: 17267834
[TBL] [Abstract][Full Text] [Related]
19. [The pill and thrombosis].
Thranov I; Obel EB
Ugeskr Laeger; 1984 Sep; 146(36):2709-11. PubMed ID: 6515890
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
